Warfarin still predominates in AF treatment

A snapshot of oral anticoagulant use in patients with atrial fibrillation shows prescriptions for non-vitamin K oral anticoagulants (NOACs) are certainly increasing, but older drugs such as warfarin still predominate.

The authors of a study of more than 11,000 AF patients note a reluctance to prescribe NOACs for clinically complex patients, despite evidence that these drugs can be safety used.

Patients are less likely to receive NOACs if they have coronary artery disease, receive pharmacological cardioversion, or have heart failure, Professor Giuseppe